Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes J Kidman, RM Zemek, JW Sidhom, D Correa, N Principe, F Sheikh, ... Oncoimmunology 13 (1), 2345859, 2024 | 2 | 2024 |
Direct in vivo CAR T cell engineering L Short, RA Holt, PR Cullis, L Evgin Trends in Pharmacological Sciences, 2024 | 3 | 2024 |
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22 S McComb, M Arbabi-Ghahroudi, KA Hay, BA Keller, S Faulkes, ... Molecular Therapy Oncology 32 (1), 2024 | 1 | 2024 |
A Synthetic Cytotoxic T cell Platform for Rapidly Prototyping TCR Function G Sharma, J Round, F Teng, Z Ali, C May, E Yung, RA Holt bioRxiv, 2023 | | 2023 |
Plasmonically coupled semiconductor quantum dots for efficient hydrogen photoelectrocatalysis M Ijaz, H Zhang, SV Chan, R Holt, NJLK Davis, RJ Blaikie Applied Physics Letters 123 (5), 2023 | 7 | 2023 |
Behavioral dissection of hunger states in Drosophila KJ Weaver, S Raju, RA Rucker, T Chakraborty, RA Holt, SD Pletcher Elife 12, RP84537, 2023 | 2 | 2023 |
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... nature genetics 55 (6), 1076-1076, 2023 | 2 | 2023 |
Effects of hunger on neuronal histone modifications slow aging in Drosophila KJ Weaver, RA Holt, E Henry, Y Lyu, SD Pletcher Science 380 (6645), 625-632, 2023 | 18 | 2023 |
Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION device SD Brown, L Dreolini, JF Wilson, M Balasundaram, RA Holt BMC bioinformatics 24 (1), 116, 2023 | 11 | 2023 |
Immune activation following Irbesartan treatment in a colorectal cancer patient: a case study E Titmuss, K Milne, MR Jones, T Ng, JT Topham, SD Brown, DF Schaeffer, ... International Journal of Molecular Sciences 24 (6), 5869, 2023 | 1 | 2023 |
Author Correction: Pan-cancer analysis of whole genomes Nature 614 (7948), E39-E39, 2023 | 1 | 2023 |
Oncomicrobial vaccines: the potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes RA Holt Cell Host & Microbe 31 (1), 141-145, 2023 | 11 | 2023 |
Author Correction: Pan-cancer analysis of whole genomes (Nature,(2020), 578, 7793,(82-93), 10.1038/s41586-020-1969-6) LA Aaltonen, F Abascal, A Abeshouse, H Aburatani, DJ Adams, ... Nature 614 (7948), E39, 2023 | | 2023 |
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies N Kekre, KA Hay, JR Webb, R Mallick, JS Nielsen, J Quizi, SD Brown, ... Frontiers in immunology 13, 1074740, 2022 | 10 | 2022 |
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus CM Rive, E Yung, L Dreolini, SD Brown, CG May, DJ Woodsworth, ... Molecular Therapy Methods & Clinical Development 26, 4-14, 2022 | 9 | 2022 |
Encoding of hunger by the neuronal epigenome slows aging in Drosophila KJ Weaver, RA Holt, E Henry, SD Pletcher Biorxiv, 2022.07. 21.501022, 2022 | 2 | 2022 |
Early Clonal Expansion of Tumour-Infiltrating Lymphocytes Predicts Response to Immune Checkpoint Therapy J Kidman, R Zemek, JW Sidhom, D Correa, N Principe, F Sheikh, VS Fear, ... | | 2022 |
Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load MS Rye, KL Garrett, RA Holt, CF Platell, MJ McCoy Plos one 17 (1), e0262416, 2022 | 8 | 2022 |
Tumor Antigen-Specific Infiltrating CD8+ Effector T Cells Memory Predict Response to Immune Checkpoint Therapy N Principe, J Kidman, S Goh, CM Tilsed, SA Fisher, VS Fear, CA Forbes, ... Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer, 2021 | | 2021 |
Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury LM Williamson, CM Rive, D Di Francesco, E Titmuss, HJE Chun, ... NPJ Precision Oncology 5 (1), 103, 2021 | 27 | 2021 |